Pneumococcal pneumonia and influenza: a deadly combination.
about
Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lungPotential impact of co-infections and co-morbidities prevalent in Africa on influenza severity and frequency: a systematic reviewRole of Autophagy and Apoptosis in the Postinfluenza Bacterial PneumoniaGlobal Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic AnalysisInfluenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of DiseaseThe anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventionsTime and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniaeInfluenza vaccines to control influenza-associated bacterial infection: where do we stand?Children hospitalised with influenza-associated pneumonia during the 2009 pandemic displayed increased disease severity.The role of influenza in the epidemiology of pneumoniaHeterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culturePulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infectionsEfficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic.Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.Preventing and treating secondary bacterial infections with antiviral agentsLethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.Invasive bacterial infections in relation to influenza outbreaks, 2006-2010.Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United StatesEffectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.The burden of acute respiratory infections in crisis-affected populations: a systematic review.Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source.Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016.Pneumonia and poverty: a prospective population-based study among children in BrazilSuccessive influenza virus infection and Streptococcus pneumoniae stimulation alter human dendritic cell function.Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccinesTemporal association in hospitalizations for tuberculosis, invasive pneumococcal disease and influenza virus illness in South African childrenPneumonia in healthy Canadian children and youth: Practice points for management.Maltose-Dependent Transcriptional Regulation of the mal Regulon by MalR in Streptococcus pneumoniaeRisk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control studyRadiological findings in 210 paediatric patients with viral pneumonia: a retrospective case studyUncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children.SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria.Influence of bacterial interactions on pneumococcal colonization of the nasopharynx.Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia.Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.Benefits to mother and child of influenza vaccination during pregnancy.
P2860
Q21131368-57770785-BA8D-4F02-AA1B-5544CA3635B5Q23909568-686F533F-0FC0-4CF6-9910-CB8366E8969EQ26744768-D087EA25-17B0-4734-AD6F-9600B6563841Q26751854-1F7B2ED2-7F27-45D5-95C1-738C551B4B71Q26799132-5D63CCCC-7685-44E7-97DC-F3B1253234F2Q28732491-FEA24D34-E365-4F67-BE4F-5B156D0E9F21Q30222430-E6244687-F474-42C9-AE84-BD9A06F73907Q30366650-F7E681A4-60D8-49CD-84B0-93DA259B1248Q30368689-3B57FD5E-29BA-4083-A9AD-C4CBC535D4ECQ30380503-07D96F75-7A2A-4CC5-B7A3-AC2C43747807Q30384444-59064D3E-B097-4E3E-B301-420FF5F53C02Q30385165-46C90718-9D37-4BD7-B235-4C5132422DF0Q30395482-BEE65D61-F89D-4DD6-A97B-1C9E2C435ABDQ30398779-1DD6503C-1DAA-4433-9962-9609BF023DC9Q30401260-E01ADAB4-CA39-4B26-A48B-F65BAFA82DB4Q30407311-F5F9A03C-0A98-48AE-A40E-7A598EBF6DD0Q30408536-7A30141D-9BBA-4CC0-937C-5A3216355163Q30410509-F30968C5-1495-43C8-B0DC-D5DB2A961782Q31072053-8D185848-3B79-4394-97E7-BCF3F74DBB34Q31112685-5919F726-AB16-4D6B-8063-75AEAB2F218BQ33691929-9455EDE9-25DE-4B3F-8980-0B528ED987CFQ33896536-562136C1-A180-494A-9111-4DDA92651E3BQ33908117-947017D7-E040-4286-9E00-EEB9A11BBB6FQ33940163-E9244B2C-579C-4CE0-B51D-75A2079AC906Q33965592-D82ED7C1-FE15-4462-8E76-AEB4C568DC78Q34663884-BEAE680D-5A50-4A6C-A708-D195C6EAE8DCQ35117599-77053AC2-59AC-4912-8B66-F53BBBA8BCCCQ35434201-0CCD1518-7B5F-4D58-9DF6-0CDD2F9E04C6Q35648539-60373883-F4C9-4563-A04C-88B35F30216FQ36141815-C48587CD-D659-4FD5-B4AE-0E55348A1E9AQ36325883-31823B2D-61E7-4A00-8E6C-800C9C89F29BQ36425466-8613B5F1-AC81-4B94-9158-6ED0586E57C2Q36728916-E93485F8-EA9F-459B-9BF6-5003AA413BDAQ36936342-73EE45DE-D104-4797-90B8-07D1C5E7045BQ37058954-5251BD78-9FA4-4964-A395-38149030359CQ37115586-C76015CF-0DF9-4DE2-A91B-0859B328CFB2Q37424992-7A8B8B9F-3C77-4817-9978-C65DF5D65EA6Q37464089-4A6604DE-30FD-48B7-B16A-A35E73D1B27CQ37857254-6E5225A1-7CB3-4886-9F28-592599FE5173Q37976536-F987293B-FC23-4A05-BB82-8B1E8E54535C
P2860
Pneumococcal pneumonia and influenza: a deadly combination.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pneumococcal pneumonia and influenza: a deadly combination.
@ast
Pneumococcal pneumonia and influenza: a deadly combination.
@en
type
label
Pneumococcal pneumonia and influenza: a deadly combination.
@ast
Pneumococcal pneumonia and influenza: a deadly combination.
@en
prefLabel
Pneumococcal pneumonia and influenza: a deadly combination.
@ast
Pneumococcal pneumonia and influenza: a deadly combination.
@en
P1433
P1476
Pneumococcal pneumonia and influenza: a deadly combination.
@en
P2093
Yu-Wen Chien
P304
P356
10.1016/J.VACCINE.2009.06.007
P407
P478
27 Suppl 3
P577
2009-08-01T00:00:00Z